Cheryl is President and CEO of the non-profit Midwest Business Group on Health
(MBGH), a coalition of more than 150 mid, large and jumbo, self-funded, public and
private companies who represent more than 4M lives. She oversees all coalition
activities including advocacy, membership, administration, research projects and
educational activities, working closely with MBGH’s employer-led Board of Directors
to establish the strategic direction of the coalition. She also leads MBGH’s National
Employer Initiative on Specialty Drugs, the first major purchaser-driven research
project that supports employers in managing the higher costs of biologic and
specialty drugs by helping them make critical and informed decisions.
Cheryl joined MBGH in 1983 as the Director of Membership Development, returning
in 2006 as Vice President, after spending 10 years with a population health
management company. In 2018, she became President & CEO.
Cheryl is a nationally recognized speaker on employer best practices in managing
specialty drugs, value-based benefit design, wellbeing, consumerism, engagement
and benefit communications. She currently serves on multiple boards and
committees representing the purchaser perspective, including the Institute of
Medicine Chicago – Board of Directors and Fellow, National Alliance of Healthcare
Purchasing Coalitions – Board of Governors, University of Michigan Value Based
Insurance Design (VBID) – National Task Force on Low-Value Care